Topcon partners with IBM for Merge Eye Station and Eye Care PACS users
Category: #health  By Mateen Dalal  Date: 2019-10-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Topcon partners with IBM for Merge Eye Station and Eye Care PACS users

Ophthalmic device usage and production are projected to witness an exponential growth in the near future due to the growing prevalence of eye conditions. Various pharmaceutical firms across the world are increasingly turning towards the usage of ophthalmic devices while bigger firms are passing their customers to other firms having usage of these devices.    

One such instance was observed when, Topcon Healthcare Solutions, a leading manufacturer of ophthalmic devices and software solutions for eye care, reportedly announced that it is collaborating with IBM Watson Health, an IBM subsidiary committed towards creation of smarter health ecosystems, to support the formation of a transition plan for their web-based image management platform Merge Eye Care PACS™ and Merge Eye Station™, a digital fundus imaging platform.

Both products that fall under IBM’s global eye care division which are being EOL (end-of-lifed) as announced by the firm earlier. 

The move comes ahead of IBM plans to stop its consumer support for Merge Eye Station and Merge Eye Care PACS users by 2020 end, Topcon would offer a safe transition path to its customers, enabling them to migrate the information to its signature data management system, Harmony.

Topcon’s Harmony system lets customers automatically import reports and images from various diagnostic devices integrated to one web-based viewer. Topcon Harmony would offer seamless information migration from Merge and would also support all users of Eye Station irrespective of existing hardware.

Additionally, Topcon would also provide a trade-in support program which provides IBM’s existing Merge customers the capability to upgrade to the Topcon’s latest imaging technology. 

President at Topcon Healthcare Solutions, Akifumi Baba stated that the company is thrilled to welcome all IBM’s Merge consumers to its software ecosystem. Topcon’s team has been diligently working for the development of a suite of applications that would allow Merge Eye Station and Merge Eye Care PACS users to effortlessly transition to Topcon Harmony.

Akifumi added that the Topcon Healthcare Suite has various applications that integrate a core array of technologies that would support Merge users during this transition and would provide them a safe future as their software requirements evolve along with the continuously changing healthcare landscape.

Source credit: https://finance.yahoo.com/news/topcon-healthcare-selected-ease-transition-140000952.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
By Mateen Dalal

Air France–KLM S.A., one of the leading global air transport players, has reportedly made a proposal to invest in Malaysia Airlines and gain around 49 percent stake. Japan Airlines (JAL) is also looking to acquire a 25 percent stake in Mal...

Accenture opens innovation center in South Beach Road office
Accenture opens innovation center in South Beach Road office
By Mateen Dalal

Accenture, an Irish multinational professional services company, has recently opened a global innovation center within the Accenture’s office at South Beach Road, which is supported by EDB (Economic Development Board) in Singapore. It will pro...

Verrica unveils positive data from VP-102 study in molluscum treatment
Verrica unveils positive data from VP-102 study in molluscum treatment
By Mateen Dalal

Findings from the study are being produced at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast The data indicated a considerable increase in the percentage of patients with lesion clearance in VP-102 group Verrica Pharmaceu...